Enoxaparin
Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Enoxaparin and local guidelines before prescribing.
Mechanism
Low molecular weight heparin enhancing antithrombin activity against factor Xa.
Uses
VTE prophylaxis and treatment, ACS, bridging anticoagulation.
Dosing
- Enoxaparin | NSTEMI: 1 mg/kg SC twice daily. STEMI: see Anticoagulation for age- and renal-adjusted regimens.
Cardiology: Ischaemic Heart Disease (ACS) › 1.33 Drug Reference Table - VTE prophylaxis in hospital (NICE NG89) - assess every adult on admission for VTE and bleeding risk; LMWH (e.g. enoxaparin 40 mg daily, adjusted for weight and kidney function) or fondaparinux; mechanical options (intermittent pneumatic compression - not anti-embolism stockings in acute stroke ); reassess regularly.
Haematology: Anatomy Physiology and Pharmacology - LMWH (e.g. enoxaparin 40 mg once daily ; 20 mg if creatinine clearance is under 30), or fondaparinux, for at least 7 days if risk outweighs bleeding risk.
Haematology: Haemostasis and Thrombosis - Enoxaparin Prophylaxis 40 mg daily; treatment 1.5 mg/kg daily | Reduce if CrCl under 30; anti-Xa monitoring in pregnancy and extremes of weight.
Haematology: Haemostasis and Thrombosis
3 more dose entries from the chapters
- Pharmacological prophylaxis - usually LMWH (e.g. enoxaparin 40 mg daily, adjusted for weight and kidney function), starting 6–12 hours after surgery (timing around neuraxial anaesthesia matters), continued until mobility returns (often at least 7 days for major surgery).
Surgery: Surgical principles and perioperative care - Pharmacological prophylaxis - LMWH (e.g. enoxaparin 40 mg daily - adjust for weight and kidney function) or fondaparinux, for at least 7 days if VTE risk outweighs bleeding risk; unfractionated heparin in severe kidney impairment (eGFR under 15–30).
Acute Medicine: The acute medical take - VTE prophylaxis (NICE NG89) - assess risk on admission; LMWH (e.g. enoxaparin 40 mg SC once daily, adjusted for weight and renal function) unless contraindicated (active bleeding, low platelets, recent stroke with haemorrhage); mechanical prophylaxis (anti-embolism stockings) for some surgical patients - not after stroke.
OSCEs II: Practical procedures, prescribing and acute care stations
Side effects
Bleeding, injection-site bruising, thrombocytopenia (HIT), hyperkalaemia, elevated transaminases.
Interactions
Anticoagulants, antiplatelets, NSAIDs and SSRIs increase bleeding.
Contraindications and cautions
Active bleeding, HIT history
Monitoring
Platelets, anti-Xa in renal impairment
Pregnancy and breastfeeding
Used in pregnancy
Renal and hepatic impairment
Reduce dose if CrCl below 30
Overdose and reversal
Protamine partially reverses
Special advice
Dose by weight; reduce in severe renal impairment; platelet counts during prolonged use; neuraxial anaesthesia timing.
More from the textbook: uses, cautions and other points
- Low molecular weight heparin (enoxaparin, dalteparin, tinzaparin) - subcutaneous, weight-based dosing; mainly anti-Xa ; renally excreted (reduce dose with low creatinine clearance); monitor anti-Xa levels in pregnancy, extremes of weight or CKD; only partly reversed by protamine.
Cardiology: Anatomy Physiology and Pharmacology - 5. A 72-year-old woman develops a DVT on day 8 of enoxaparin after hip surgery. Platelets have fallen from 310 to 110. Answer: Heparin-induced thrombocytopenia.
Cardiology: Anatomy Physiology and Pharmacology - Enoxaparin / dalteparin | SC by weight; reduce if CrCl under 30; anti-Xa monitoring in pregnancy, CKD, extreme weight; HIT, hyperkalaemia.
Haematology: Anatomy Physiology and Pharmacology - Platelets fall from 280 to 95 on day 7 of enoxaparin, new DVT | HIT - stop all heparin, non-heparin anticoagulant
Haematology: Anatomy Physiology and Pharmacology - LMWH (enoxaparin, dalteparin, tinzaparin) | Weight-based; reduce in severe kidney impairment; monitor platelets if exposed to unfractionated heparin recently (HIT); anti-Xa levels in pregnancy, kidney failure or extremes of weight
Haematology: Haemostasis and Thrombosis - Enoxaparin / tinzaparin (LMWH) | VTE prophylaxis and treatment; dose by booking weight.
Obstetrics: Medical Problems
Where it is discussed in the book
- Cardiology: Anatomy Physiology and Pharmacology (2 mentions)
- Cardiology: Ischaemic Heart Disease (ACS) (1 mention)
- Haematology: Anatomy Physiology and Pharmacology (4 mentions)
- Haematology: Haemostasis and Thrombosis (3 mentions)
- Obstetrics: Medical Problems (1 mention)
- Surgery: Surgical principles and perioperative care (1 mention)
- Clinical pharmacology and prescribing: Safe prescribing, prescription writing and medicines law (1 mention)
- Clinical pharmacology and prescribing: Prescribing in special groups (2 mentions)
- Clinical pharmacology and prescribing: High-risk drugs, therapeutic drug monitoring, IV fluids and antimicrobial prescribing (1 mention)
- Acute Medicine: The acute medical take (2 mentions)
- Anaesthesia: Preoperative assessment and principles of anaesthesia (1 mention)
- Integrated cardiology chapter (1 mention)
- OSCEs II: Practical procedures, prescribing and acute care stations (1 mention)